(688331)"REMEGEN CO., LTD."Announcement on the Company's Recent Production and Operation
Filed with SSE · Stock code 688331 · · 4 pages · Chinese
Summary by 6ix AI
RemeGen Co. Ltd. has announced its recent production and operational status, highlighting the company's stable supply chain and ongoing commercialization of core products. The report details significant revenue growth and a turnaround in net profit, indicating improved financial health compared to the previous period. Additionally, the company outlines advancements in its key products and international collaborations that enhance its market position. Future plans include a focus on innovation in autoimmune and oncology treatments, alongside efforts to expand international partnerships.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/688331remegen-co-ltdannouncement-on-the-companys-recent-production-and-operation
Story so far
- (688331)"REMEGEN CO., LTD."Announcement on Progress of Initial Repurchase of Shares through Call Auction in 2026
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- Announcement on Adjustment of Members of Special Committees of the Board of Directors
Earlier from RemeGen
- (688331)"REMEGEN CO., LTD."Announcement on Progress of Initial Repurchase of Shares through Call Auction in 2026
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- Announcement on Adjustment of Members of Special Committees of the Board of Directors
- Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026
- Announcement on Progress of the First Repurchase of Company Shares in 2026 through Call Auction
Later from RemeGen
- (688331)"REMEGEN CO., LTD."Announcement on Proposal by the Actual Controller and Chairman for the Company to Repurchase Shares
- (688331)"REMEGEN CO., LTD."Announcement on Resolutions of the 5th Meeting of the 3rd Board of Directors
- (688331)"REMEGEN CO., LTD."Report for Q3 2026
- (688331)"REMEGEN CO., LTD."Announcement on Resolutions of the 6th Meeting of the 3rd Board of Directors
- (688331)"REMEGEN CO., LTD."Proposal on the Second Share Repurchase through Call Auction in 2026
Follow RemeGen into a list and get an email when it puts out news.
Follow RemeGen